These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9833692)

  • 1. Numerical aberrations of chromosome 17 in interphase cell nuclei of breast carcinoma cells: lack of correlation with abnormal expression of p53, neu and nm23 protein.
    Sauer T; Beraki K; Jebsen PW; Ormerod E; Naess O
    APMIS; 1998 Oct; 106(10):921-7. PubMed ID: 9833692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy.
    Sauer T; Furu I; Beraki K; Jebsen PW; Ormerod E; Naess O
    Cancer; 1998 Apr; 84(2):109-14. PubMed ID: 9570214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Numerical abnormalities of chromosome 7 in interphase cell nuclei of breast carcinoma have no impact on immunohistochemically determined EGFR status.
    Sauer T; Beraki K; Jebsen PW; Naess O
    APMIS; 1999 Feb; 107(2):211-6. PubMed ID: 10225319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
    Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
    Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation.
    Bertheau P; Steinberg SM; Merino MJ
    Hum Pathol; 1998 Apr; 29(4):323-9. PubMed ID: 9563780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
    Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein.
    Han S; Yun IJ; Noh DY; Choe KJ; Song SY; Chi JG
    J Surg Oncol; 1997 May; 65(1):22-7. PubMed ID: 9179263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of nm23 expression and chromosome 17 numerical aberrations in primary gastric cancer.
    Terada R; Yasutake T; Nakamura S; Hisamatsu T; Sawai T; Yamaguchi H; Nakagoe T; Ayabe H; Tagawa Y
    Med Oncol; 2002; 19(4):239-48. PubMed ID: 12512918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. nm23 expression in advanced and borderline ovarian carcinoma.
    Schneider J; Romero H; Ruiz R; Centeno MM; Rodriguez-Escudero FJ
    Anticancer Res; 1996; 16(3A):1197-202. PubMed ID: 8702236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of p53, nm23-HI, Ki67 and DNA ploidy: correlation with lymph node status and other clinical pathologic parameters in breast cancer.
    Midulla C; De Iorio P; Nagar C; Pisani T; Cenci M; Valli C; Nofroni I; Vecchione A
    Anticancer Res; 1999; 19(5B):4033-7. PubMed ID: 10628350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimetastasis gene expression and numerical chromosomal abnormalities of chromosomes 1 & 17 in serous tumours of the ovary.
    Kaya H; Evans MF; Ekicioglu G; Tuzlali S; Küllü S; Foster C
    Eur J Gynaecol Oncol; 2001; 22(3):240-2. PubMed ID: 11501783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein markers in colorectal cancer: predictors of liver metastasis.
    Berney CR; Fisher RJ; Yang J; Russell PJ; Crowe PJ
    Ann Surg; 1999 Aug; 230(2):179-84. PubMed ID: 10450731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
    Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
    Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer.
    Yoshida H; Kijima H; Terasaki Y; Suto A; Takeshita T; Omiya H; Shimojima K; Shimbori M; Sato T; Sato S; Onoda N; Yamazaki H; Tamaoki N; Ueyama Y; Nakamura M
    Int J Oncol; 1998 Dec; 13(6):1141-6. PubMed ID: 9824622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of numerical chromosome 17 abnormalities in fine-needle aspirates of breast cancer using a novel in situ hybridization signal amplification method.
    Schmitt FC; Soares R; Leitão D
    Diagn Cytopathol; 1998 Aug; 19(2):141-6. PubMed ID: 9702495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ploidy analysis by in situ hybridization of interphase cell nuclei in fine-needle aspirates from breast carcinomas: correlation with cytologic grading.
    Sauer T; Beraki K; Jebsen PW; Ormerod E; Naess O
    Diagn Cytopathol; 1997 Oct; 17(4):267-71. PubMed ID: 9316782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. nm23 protein expression and p53 immunoreactivity in cutaneous fibrohistiocytic tumors.
    Lee CS; Clarke RA; Tran KT; Kearsley JH; Chou ST
    Pathology; 1999 May; 31(2):123-6. PubMed ID: 10399167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma.
    MacKinnon M; Kerr KM; King G; Kennedy MM; Cockburn JS; Jeffrey RR
    Eur J Cardiothorac Surg; 1997 May; 11(5):838-42. PubMed ID: 9196297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.